Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Colgate restructuring

This article was originally published in The Tan Sheet

Executive Summary

Firm is on track with its current restructuring initiative, which is expected to result in savings of $40 mil.-$50 mil. this year, CEO Reuben Mark reports during a presentation at the Sanford C. Bernstein Strategic Decisions Conference June 1. The plan, announced in December, is aimed at generating savings of $250 mil.-$300 mil. over four years (1"The Tan Sheet" Dec. 13, 2004, p. 14). Colgate will maintain its strategy of focusing on limited categories such as oral care, while "play[ing] down" or divesting other segments, Mark said. The firm will continue to back its oral care franchise with promotional spending despite escalating material costs, the exec notes...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098275

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel